Alaska State Overview

Electronic Medical Records (EMR) represents a growing market for a large number of companies, with customer demand, heavy competition and government incentives spurring revenues.   This Kalorama Information report, EMR  |  read more...

BMI View: As a developed market, Australia represents opportunities for risk averse pharmaceuticalinvestors, given its ageing and generally affluent population. Importantly, the government is implementingcost-cutting measures to cope with escalating healthcare costs, therefore generic drugmakers  |  read more...

BMI View: We expect Namibia's negative pharmaceutical trade balance to widen as demand for medicinescontinues to be met by imports, and poor local manufacturing sees exports contract in the medium term.Headline Expenditure Forecasts Pharmaceuticals: NAD2.20bn  |  read more...

In the context of South African healthcare system, which struggles with the enormous healthcare needs of a large population and has few healthcare providers, innovative solutions are needed to mitigate healthcare workforce shortage problems. While  |  read more...

BMI View: The risks of investing in Côte d'Ivoire's pharmaceutical and healthcare industry arenumerous. Politically, the country is in a fragile state, with concerns over security commonplace.Economically, Côte d'Ivoire posts a better performance, but there  |  read more...